Usefulness of 18F-FDG PET/CT in Patients with Cardiac Implantable Electronic Device Suspected of Late Infection

• Published in: Journal of clinical medicine Vol. 9; no. 7; p. 2246
• Main Authors: Rubini, Giuseppe, Ferrari, Cristina, Carretta, Domenico, Santacroce, Luigi, Ruta, Rossella, Iuele, Francesca, Lavelli, Valentina, Merenda, Nunzio, D’Agostino, Carlo, Sardaro, Angela, Niccoli Asabella, Artor
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 15-07-2020; MDPI
• Subjects: Cancer; Cardiology; Clinical medicine; Infections; Patients; Software; Statistical analysis; Surveillance; Tomography; United States > US; Wisconsin
• ISSN: 2077-0383; 2077-0383
• DOI: 10.3390/jcm9072246

The presence of a cardiovascular implantable electronic device (CIED) can be burdened by complications such as late infections that are associated with significant morbidity and mortality and require immediate and effective treatment. The aim of this study was to evaluate the role of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography (18F-FDG PET/CT) in patients with suspected CIED infection. Fifteen patients who performed a 18F-FDG PET/CT for suspicion of CIED infection were retrospectively analyzed; 15 patients, with CIED, that underwent 18F-FDG PET/CT for oncological reasons, were also evaluated. Visual qualitative analysis and semi-quantitative analysis were performed. All patients underwent standard clinical management regardless 18F-FDG PET/CT results. Sensitivity, specificity, accuracy, positive predictive value (PPV) and negative predictive value (NPV) resulted as 90.91%, 75%, 86.67%, 90.91% and 75% respectively. Maximum standardized uptake values (SUVmax) and semi-quantitative ratio (SQR) were collected and showed differences statistically significant between CIED infected patients and those who were not. Exploratory cut-off values were derived from receiver operating characteristic (ROC) curves for SUVmax (2.56) and SQR (4.15). This study suggests the clinical usefulness of 18F-FDG PET/CT in patients with CIED infection due to its high sensitivity, repeatability and non-invasiveness. It can help the clinicians in decision making, especially in patients with doubtful clinical presentation. Future large-scale and multicentric studies should be conducted to establish precise protocols about 18F-FDG PET/CT performance.